MISSION

To bring scientists, executives and other biopharmaceutical professionals from the Pacific Rim countries together to discuss the latest advances in the biotechnology/pharmaceutical world, the unprecedented challenges and promises facing the industry, and the breathtaking developments and opportunities in Asia/Pacific countries.

About BioPacific Conference
    The BioPacific Conference is the annual flagship event of the CABS. Our mission is to bring scientists, executives and biopharmaceutical professionals from the Pacific Rim countries together to discuss the latest advances in the world of life sciences, the unprecedented challenges and promises facing the industry, and the breathtaking developments and opportunities in Asia/Pacific countries.

BioPacific Conference 2019 (aka 20th Annual Conference of CABS, Chinese- American BioPharmaceutical Society), will be held on June 22th, 2019 in the San Mateo Marriott San Francisco Airport, 1770 South Amphlett Blvd, San Mateo, CA 94402. This full-day event is expected to attract over 600+ attendees of life science professionals from the great San Francisco Bay Area.

Date and Time: June 22th, 2019 @ 8:00 am – @ 7:00 pm

Location: San Mateo Marriott San Francisco Airport, 1770 South Amphlett Blvd, San Mateo, CA 94402
The theme of the BioPacific Conference 2019 will be “Pursuing Science for Cure”

Our meeting will showcase:
  • 10 years growth story of BeiGene: how the leading Chinese biotech achieved 7 billion of market cap
  • Cure HIV: Gilead’s next battle after its success in HCV
  • Denali’s new approaches for neurodegenerative disease
  • Discovery story behind Talazoparib: 2018 approved therapeutics for breast cancer
  • The recent advances in cancer biomarker and precision medicine
  • Next wave of cancer therapies and combinations
  • The latest foreign investment regulation and policy
2018 CONFERENCE SPEAKERS
Dr. Nils Lonberg, PhD, Senior VP, Oncology Discovery Biology, Bristol-Myers Squibb
Dr. Chris Chen, PhD, CEO,WuXi Biologics
Dr. Sylvaine Cases, PhD, Vice President, Oncology Scientific Innovation, Janssen Pharmaceutical Companies of Johnson & Johnson
Dr. Li Zhu, Chief Strategy Officer, Nanjing Legend Biotech and GenScript Biotechnology, Nanjing, China
Dr. Deborah Charych, PhD, Executive Director, Nektar Therapeutics
Dr. Dan Zhang, MD, MA, MPH, Chairman, Fountain Medical Development (FMD)
Dr. Guoliang Yu, PhD, Executive Chairman, Crown Bioscience; Venture Partner, OrbiMed Venture
Dr. Yuling Luo, PhD, Founder, Chairman, and CEO Alamar Biosciences
Dr. Scott Liu, PhD, President and CEO, Shanghai Henlius Biotech, Inc.
Mr. Yiding（Mike）Chen, Founder and CEO, ACROBiosystems
Dr. Janet Xiao, PhD, JD, Partner, Co-chair, Global Life Sciences Group, Morrison & Foerster
Dr. Li Feng, PhD, Partner, Finnegan
Ms. Wilson Lee, Director, Sino-Singapore (Chengdu) Innovation Park Development
Dr. Daniel Pierce, PhD, Senior Director of Translational Medicine, Celgene
Dr. Kenneth Fong, PhD, Chairman, Kenson Ventures
Dr. Qingcong Lin, PhD, CEO, BioCytogen
Mr. Tao Chen, Co-founder and CEO, Paragon Genomics
Dr. Xueheng (Shawn) Cheng, PhD, Chief Technology Officer, Viva Biotech Ltd.
Dr. John Ning, MD, PhD, Clinical Consultant in Clinical Science and Product Development Oncology for Genentech
Dr. Jimmy Zhang, PhD, MBA, Venture Partner, Lilly Asia Ventures
Dr. Cheni Kwok, PhD, CLP, Managing Partner & Founder, Linear Dreams
Dr. Steven X. Cui, PhD, JD, Owner, TransPac IP
Dr. Huijun Zhou, PhD, Founder and CEO, iDNA
Ms. Grace Xu, MBA, Chairperson, Dendreon; Senior Vice President, Sanpower Group
Dr. Liyu Wu, PhD, Senior Director, US Pharmaceutical Business Development and Project Management, Novogene
Dr. Brooke Rock, PhD, Principal Scientist, Amgen
Dr. Rufus Pichler, JD, Partner, Morrison & Foerster
Dr. Jingrong Li, PhD, VP of CMC/Manufacturing, CStone (Suzhou) Pharmaceuticals
Mr. Rajeev Dadoo, PhD, MBA, Partner, SR One
Ms. Angela Rusakova, Master of Economics, Partner, Deloitte & Touche
Mr. Xiao-Jun Ma, PhD, Chief Scientific Officer, Advanced Cell Diagnostics
Dr. Nelson Lin, PhD, Director, Global Commercial Development, AbbVie
and more